Abstract:Background: Regulating epithelial-to-mesenchymal transition (EMT) in cancer cells has been widely considered as an approach to combat cancer progression and therapeutic resistance, whereas a limited number of broadly comprehensive investigations of miRNAs involved in metastatic colorectal cancer (mCRC) have been conducted. In this study, we investigated the roles and mechanisms of EMT process in mCRC. Methods: We used ISH and RT-qPCR to measure expression of miR93 in CRC tissues, nontumor tissues and metastatic liver tissues. CRC cell lines were transduced with lentiviruses expressed miR93. Its inhibitor sequence targeted miR93 or a scrambled sequence (control). Proliferation, metastasis, invasion and colony formation and growth of CRC cells which overexpress miR93 or its inhibitor in severe combined immune-deficient mice were analysed. Western blot, and luciferase assays were used to measure expression of Eph tyrosine kinase receptor (EphA4) and related signalling molecules. Results: In this study, we demonstrated that miR93 regulated EMT process by targeting EphA4 in mCRC. CRC tissues and metastatic liver tissues had increased levels of miR93 compared with the nontumor tissues and cells, and miR93 can regulate EMT process. Overexpression of miR93 increased proliferation of CRC cells, metastasis, invasion and colony formation in vitro, whereas miR93 depletion reduced these parameters. In nude mice, overexpression of miR93 by CRC cells increased liver metastasis and overexpression of the miR93 inhibitor reduced it. Then we identified by microarray analysis that the direct and functional target genes of miR93 was EphA4. Knockdown of EphA4 phenocopied the effect of miR-93 and ectopic expression of EphA4 restored the effect of miR93 on proliferation, migration, invasion and liver metastasis in CRC cells. Conclusions: Our findings revealed miR93 regulates EMT process by targeting EphA4 to affect liver metastasis in CRC. miR93 inhibited tumor metastasis by directly targeting EphA4, a crucial factor in regulating EMT. Collectively, this study provides new insights into exploring the therapeutic potential of miR93, which is able to regulate EMT process to affect tumor metastasis, and warrant further study in clinical settings. Clinical trial indentification: The present study was supported in part by grants from the Health and Family Planning Commission of Shanxi Province (No.2015049), the Applied Basic Research Programs of Shanxi Science and Technology Department (No.201601D011128). Legal entity responsible for the study: The Health and Family Planning Commission of Shanxi Province, the Applied Basic Research Programs of Shanxi Science and Technology Department Funding: The Health and Family Planning Commission of Shanxi Province, the Applied Basic Research Programs of Shanxi Science and Technology Department Disclosure: All authors have declared no conflicts of interest.

MiR-29c Mediates Epithelial-to-mesenchymal Transition in Human Colorectal Carcinoma Metastasis Via PTP4A and GNA13 Regulation of Β-Catenin Signaling.

Microrna-29a Promotes Colorectal Cancer Metastasis by Regulating Matrix Metalloproteinase 2 and E-Cadherin Via Klf4

Mir-129-5p Attenuates Cell Proliferation and Epithelial Mesenchymal Transition Via HMGB1 in Gastric Cancer

Mir-139-5p Inhibits the Epithelial-Mesenchymal Transition and Enhances the Chemotherapeutic Sensitivity of Colorectal Cancer Cells by Downregulating BCL2

Mir-93 Regulates Epithelial-to-mesenchymal Transition Process in Metastatic Colorectal Cancer by Targeting EphA4

MiR-452 Promotes an Aggressive Colorectal Cancer Phenotype by Regulating a Wnt/β-catenin Positive Feedback Loop

MicroRNA-9 Up-Regulation is Involved in Colorectal Cancer Metastasis Via Promoting Cell Motility

LINC01272/miR-876/ITGB2 axis facilitates the metastasis of colorectal cancer via epithelial-mesenchymal transition

MiR-185-3p regulates epithelial mesenchymal transition via PI3K/Akt signaling pathway by targeting cathepsin D in gastric cancer cells

Mir-375 Inhibits the Invasion and Metastasis of Colorectal Cancer Via Targeting SP1 and Regulating EMT-associated Genes.

EMT‐cancer cells‐derived exosomal miR‐27b‐3p promotes circulating tumour cells‐mediated metastasis by modulating vascular permeability in colorectal cancer

MicroRNA-146a Promote Cell Migration and Invasion in Human Colorectal Cancer Via Carboxypeptidase M/src-FAK Pathway

TRIM29 facilitates the epithelial-to-mesenchymal transition and the progression of colorectal cancer via the activation of the Wnt/β-catenin signaling pathway

miR-944 Suppresses EGF-Induced EMT in Colorectal Cancer Cells by Directly Targeting GATA6

circEIF3I Promotes Colorectal Cancer Metastasis by Regulating the miR‐328‐3p/NCAPH Axis

MiR-92a Promotes Cell Metastasis of Colorectal Cancer Through PTEN-Mediated PI3K/AKT Pathway

Regulation of ERα-dependent breast cancer metastasis by a miR-29a signaling

MicroRNAs Are Key Molecules Involved in the Gene Regulation Network of Colorectal Cancer

MiR-29b-3p Inhibits Migration and Invasion of Papillary Thyroid Carcinoma by Downregulating COL1A1 and COL5A1

Decreased Expression of Mir‑490‑3p in Colorectal Cancer Predicts Poor Prognosis and Promotes Cell Proliferation and Invasion by Targeting RAB14.

MicroRNA-142-3p Inhibits Tumorigenesis of Colorectal Cancer via Suppressing the Activation of Wnt Signaling by Directly Targeting to β-Catenin